Target intelligence / Profile preview

Cellular redox metabolism and reactive oxygen species production machinery (ROS/Redox Machinery)

Target
ROS/Redox Machinery
Molecular classification
Enzyme, Mitochondrial complex, Metabolic pathway, Other
01

Overview

The cellular redox metabolism and reactive oxygen species (ROS) production machinery is an integrated network of enzymes and pathways that regulate the balance between oxidant generation and antioxidant defense (Sies et al., 2017). Key components include ROS-generating enzymes such as NADPH oxidases (NOX), xanthine oxidase, and the mitochondrial electron transport chain, which are counterbalanced by antioxidant systems like superoxide dismutase (SOD), catalase, and the glutathione/thioredoxin pathways (Finkel, 2011). This machinery is vital for physiological signaling (oxidative eustress), where low levels of ROS regulate cell proliferation and differentiation; however, its dysregulation leads to oxidative distress and macromolecular damage (Murphy, 2009). Chronic oxidative stress is a central driver in the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases (Holmström & Finkel, 2014). Pharmacological strategies targeting this system include direct ROS scavengers, mitochondria-targeted antioxidants like MitoQ, and Nrf2 activators that bolster endogenous defenses, though the challenge remains to selectively target pathological ROS without impairing essential signaling (Chandel & Tuveson, 2014).

Other names
Redox homeostasis systemOxidative stress machineryROS generating systemAntioxidant defense systemRedoxome
02

Mechanism of action

Modulation of cellular redox state through the inhibition of ROS-generating enzymes, direct scavenging of reactive species, or the induction of antioxidant gene expression via the Nrf2 pathway.

03

Biological functions

Redox signalingCellular homeostasisMetabolismApoptosisSignal transductionOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAging-related pathologyOther
05

Safety considerations

Interference with physiological ROS signaling (hormesis)Potential for pro-oxidant effectsLack of clinical efficacy in broad antioxidant trialsSystemic toxicity from broad redox modulation
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Glutathione (GSH/GSSG) ratioProtein carbonyls4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Cellular redox metabolism and reactive oxygen species production machinery (ROS/Redox Machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular redox metabolism and reactive oxygen species production machinery (ROS/Redox Machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call